Holdings of Frazier Life Sciences Management, L.P.
35 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 73.2 % of the equity sleeve
Sector breakdown
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 97.4 %
- KY 1.1 %
- DK 0.9 %
- FR 0.4 %
- GB 0.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 31 | 3.2B $ | 97.38 % |
| 2 | KY | 1 | 35.8M $ | 1.08 % |
| 3 | DK | 1 | 30.5M $ | 0.92 % |
| 4 | FR | 1 | 14.3M $ | 0.43 % |
| 5 | GB | 1 | 6.1M $ | 0.19 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Mirum Pharmaceuticals Inc | 7,679,684 | 709.4M $ | |
| 2 | Erasca Inc | 24,675,188 | 399.2M $ | |
| 3 | Bridgebio Pharma Inc | 3,448,139 | 256.1M $ | |
| 4 | Arcutis Biotherapeutics Inc | 9,874,511 | 232.6M $ | |
| 5 | MBX Biosciences Inc | 6,652,013 | 198.6M $ | |
| 6 | Phathom Pharmaceuticals Inc | 12,466,489 | 138.5M $ | |
| 7 | Maze Therapeutics Inc | 4,567,274 | 136.3M $ | |
| 8 | Krystal Biotech Inc | 481,307 | 124.3M $ | |
| 9 | Trevi Therapeutics Inc | 9,939,547 | 118.6M $ | |
| 10 | Palvella Therapeutics Inc | 882,400 | 110M $ | |
| 11 | KalVista Pharmaceuticals Inc | 4,961,108 | 99.9M $ | |
| 12 | Disc Medicine Inc | 1,354,852 | 86.6M $ | |
| 13 | Cytokinetics Inc | 1,159,879 | 76.4M $ | |
| 14 | Revolution Medicines Inc | 675,686 | 65.7M $ | |
| 15 | Dyne Therapeutics Inc | 3,153,082 | 57.2M $ | |
| 16 | Savara Inc | 9,720,852 | 53.1M $ | |
| 17 | Tarsus Pharmaceuticals Inc | 728,644 | 51.1M $ | |
| 18 | Vor BioPharma Inc | 2,543,939 | 45.4M $ | |
| 19 | Agios Pharmaceuticals Inc | 1,256,080 | 42.5M $ | |
| 20 | BioCryst Pharmaceuticals Inc | 4,009,240 | 38.2M $ | |
| 21 | ZAI LAB LTD | 1,902,320 | 35.8M $ | |
| 22 | Aura Biosciences Inc | 5,100,000 | 34.1M $ | |
| 23 | ACADIA Pharmaceuticals Inc | 1,438,198 | 32M $ | |
| 24 | Ascendis Pharma A/S | 133,333 | 30.5M $ | |
| 25 | Lexeo Therapeutics Inc | 4,424,725 | 25.4M $ | |
| 26 | Aclaris Therapeutics Inc | 4,925,374 | 18.5M $ | |
| 27 | Monte Rosa Therapeutics Inc | 1,000,000 | 16.5M $ | |
| 28 | Immunocore Holdings PLC | 484,782 | 14.6M $ | |
| 29 | MannKind Corp | 5,900,000 | 14.5M $ | |
| 30 | VALNEVA SE | 2,291,666 | 14.3M $ | |
| 31 | Evolus Inc | 2,630,665 | 10.8M $ | |
| 32 | Allogene Therapeutics Inc | 3,796,668 | 9.3M $ | |
| 33 | Autolus Therapeutics PLC | 4,447,910 | 6.1M $ | |
| 34 | IBIO INC | 1,953,467 | 3.7M $ | |
| 35 | Xilio Therapeutics Inc | 422,505 | 3.6M $ | |